The U.S. Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals) ...

Experts recommend 5 peptide-based medications for weight loss, such as liraglutide and semaglutide. They require medical ...

The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a ...

The ongoing shortage of liraglutide injection and other GLP-1 medications prompted the FDA to prioritize the generic drug applications for these medications in order to improve patient access.

The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...

Patients who have a family history of medullary thyroid carcinoma and multiple endocrine neoplasia syndrome Type 2 are not ...

Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...

The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who ...

The approval is for the generic versions of Victoza to treat Type-2 Diabetes and Saxenda used in the treatment of weight ...

Biocon Ltd, in collaboration with Zentiva, has obtained EU approval for the complex formulation Liraglutide, a generic ...

Authorized generics are the exact copies of branded drugs, sold by another company with the branded drug manufacturer’s ...